Article info

Download PDFPDF

Original research
Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Authors

  1. Correspondence to Professor Takuji Gotoda, Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo 101-8309, Japan; takujigotoda{at}yahoo.co.jp
View Full Text

Citation

Suzuki S, Gotoda T, Kusano C, et al
Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan

Publication history

  • Received September 27, 2019
  • Revised December 4, 2019
  • Accepted December 25, 2019
  • First published January 8, 2020.
Online issue publication 
May 07, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.